Sunesis Pharmaceuticals (SNSS) Reports Strong Q1 Results
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
General and administrative: 4M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 4M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported Q1 EPS of $0.04, $0.18 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4 million, versus $13 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
